These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 26240945)

  • 1. Low use of effective and safe therapies for moderate to severe menopausal symptoms: a cross-sectional community study of Australian women.
    Worsley R; Bell RJ; Gartoulla P; Davis SR
    Menopause; 2016 Jan; 23(1):11-7. PubMed ID: 26240945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years.
    Gartoulla P; Worsley R; Bell RJ; Davis SR
    Menopause; 2015 Jul; 22(7):694-701. PubMed ID: 25706184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years.
    Gartoulla P; Worsley R; Bell RJ; Davis SR
    Menopause; 2018 Nov; 25(11):1331-1338. PubMed ID: 30358730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).
    Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C;
    Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of complementary and alternative medicines for menopausal symptoms in Australian women aged 40-65 years.
    Gartoulla P; Davis SR; Worsley R; Bell RJ
    Med J Aust; 2015 Aug; 203(3):146, 146e.1-6. PubMed ID: 26224187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study.
    Zeleke BM; Bell RJ; Billah B; Davis SR
    Fertil Steril; 2016 Jan; 105(1):149-55.e1. PubMed ID: 26450529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms.
    Constantine GD; Revicki DA; Kagan R; Simon JA; Graham S; Bernick B; Mirkin S
    Menopause; 2019 May; 26(5):513-519. PubMed ID: 30516713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
    Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate-Severe Vasomotor Symptoms Are Associated with Moderate-Severe Depressive Symptoms.
    Worsley R; Bell RJ; Gartoulla P; Robinson PJ; Davis SR
    J Womens Health (Larchmt); 2017 Jul; 26(7):712-718. PubMed ID: 28263691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.
    Simon JA; Kaunitz AM; Kroll R; Graham S; Bernick B; Mirkin S
    Menopause; 2019 May; 26(5):506-512. PubMed ID: 30489424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and severity of vasomotor symptoms and joint pain in women at midlife in Bangladesh: a population-based survey.
    Islam RM; Bell RJ; Billah B; Hossain MB; Davis SR
    Menopause; 2016 Jul; 23(7):731-9. PubMed ID: 26926325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-cultural study: experience, understanding of menopause, and related therapies in Australian and Laotian women.
    Sayakhot P; Vincent A; Teede H
    Menopause; 2012 Dec; 19(12):1300-8. PubMed ID: 22929035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasomotor symptoms are associated with depressive symptoms in community-dwelling older women.
    Zeleke BM; Bell RJ; Billah B; Davis SR
    Menopause; 2017 Dec; 24(12):1365-1371. PubMed ID: 28640158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bothersome menopausal symptoms amongst postmenopausal Iranian women.
    Fooladi E; Bell RJ; Masoumi M; Azizi M; Atarod Z; Davis SR
    Climacteric; 2018 Dec; 21(6):586-593. PubMed ID: 30145921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the patient with menopausal symptoms.
    Martin KA; Manson JE
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4567-75. PubMed ID: 19056840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
    Ruiz AD; Daniels KR
    Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact and management of symptoms experienced at midlife: a community-based study of women in northeast Scotland.
    Duffy OK; Iversen L; Hannaford PC
    BJOG; 2012 Apr; 119(5):554-64. PubMed ID: 22332916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom experience after discontinuing use of estrogen plus progestin.
    Ockene JK; Barad DH; Cochrane BB; Larson JC; Gass M; Wassertheil-Smoller S; Manson JE; Barnabei VM; Lane DS; Brzyski RG; Rosal MC; Wylie-Rosett J; Hays J
    JAMA; 2005 Jul; 294(2):183-93. PubMed ID: 16014592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.